Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen

Journal of Infectious Diseases

Volumn 200, Issue 8, 2009, Pages 1227-1231

  Walz, Alexander ^a   Wirth, Stefan ^a   Hucke, Jürgen ^b   Gerner, Patrick ^a,c  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b Bethesda Krankenhaus   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MOTHER CHILD RELATION; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VERTICAL TRANSMISSION;

ADULT; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; YOUNG ADULT;

EID: 70349416599     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605698     Document Type: Article

References (27)

1. Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978;298:1379-1383 (Pubitemid 8358627)
2. Thiers V, Nakajima E, Kremsdorf D, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988;2:1273-1276
3. Elghouzzi MH, Courouce AM, Magnius LO, Lunel F, Lapierre V. Transmission of hepatitis B virus by HBV-negative blood transfusion. Lancet 1995; 346:964.
4. Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995;35:5-12.
5. Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that antiHBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 1999; 107:186-195
6. Dreier J, Kroger M, Diekmann J, Gotting C, Kleesiek K. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med 2004; 14:97-103. (Pubitemid 38623072)
7. Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991; 163:397-399
8. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2002;40:4068-4071 (Pubitemid 35285791)
9. Deseos B, Scotto J, Fayol V, et al. Anti-HBc screening for the prevention of perinatal transmission of hepatitis B virus in France. Infection 1987; 15:434-439 (Pubitemid 18082259)
10. Grob P, Jilg W, Bornhak H, et al. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol 2000; 62:450-455
11. Jilg W, Sieger E, Zachoval R, Schatzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995;23:14-20.
12. Noborg U, Gusdal A, Horal P, Lindh M. Levels of viraemia in subjects with serological markers of past or chronic hepatitis B virus infection. Scand J Infect Dis 2000; 32:249-252 (Pubitemid 30601328)
13. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998; 17:6-13. (Pubitemid 28072282)
14. Infectious disease testing for blood transfusions. NIH Consens Statement 1995;13:1-27.
15. Jilg W, Hottentrager B, Weinberger K, et al. Prevalence of markers of hepatitis B in the adult German population. J Med Virol 2001; 63: 96-102. (Pubitemid 32142265)
16. Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R. Prevalence of markers for hepatitis A, B and C in the German population: results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 2001; 17:429-435 (Pubitemid 34105986)
17. Grethe S, Monazahian M, Böhme I, Thomssen R. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 1998;72:7692-7696 (Pubitemid 28377913)
18. Uchida T, Shimojima S, Gotoh K, Shikata T, Mima S. Pathology of livers infected with "silent" hepatitis B virus mutant. Liver 1994; 14: 251-256
19. Fukuda R, Ishimura N, Kushiyama Y, et al. Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis. Microbiol Immunol 1996;40:481-488
20. Dhedin N, Douvin Q Kuentz M, et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 1998;66:616-619 (Pubitemid 28433844)
21. Marusawa H, Imoto S, Ueda Y, Chiba T. Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen. J Gastroenterol 2001; 36:633-636 (Pubitemid 32962813)
22. Nordbo SA, Skaug K, Holter E, Waage A, Brinch L. Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation. Eur J Haematol 2000; 65:86-87 (Pubitemid 30432030)
23. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 2: 1099-1102. (Pubitemid 14242389)
24. del Canho R, Grosheide PM, Mazel JA, et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15:1624-1630
25. Assateerawatt A, Tanphaichitr VS, Suvatte V, In-ngarm L. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates. Asian Pac J Allergy Immunol 1991;9:89-93.
26. Tan KL, Goh KT, Oon CJ, Chan SH. Immunogenicity of recombinant yeast-derived hepatitis B vaccine in nonresponders to perinatal immunization. JAMA 1994;271:859-861 (Pubitemid 24076854)
27. Vranckx R, Alisjahbana A, Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. J Viral Hepat 1999;6:135-139 (Pubitemid 29147292)